IP Library Granted Patent US 11,638,695
Granted Patent B2
US 11,638,695 · App. 16/760,440 · Granted May 2, 2023

Development of method and apparatus for producing lipid particles having desired particle diameter

Inventor: Takashi Matsuzaki (Osaka, JP)
Assignee: OSAKA UNIVERSITY
A61K9/1277A61K45/06B01D61/28B01D61/32B01D63/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,638,695
App. No.
16/760,440
Granted
May 2, 2023
Kind
B2
Abstract

The present invention provides a method for producing lipid particles that have a desired particle diameter, the method comprising: (A) a step for preparing, in a first mixing region, a primary dilution by mixing a first solution containing a lipid and an alcohol with a second solution containing water; (B) a step for feeding the primary dilution from the first mixing region to a second mixing region through a liquid feed pipe within a prescribed time; and (C) a step for preparing a secondary dilution by mixing the primary dilution with a third solution containing water in the second mixing region, wherein the steps (A)-(C) are continuously carried out, and the particle diameter of the lipid particles is controlled by adjusting at least one condition selected from the group consisting of the concentration of the alcohol and the concentration of the lipid in the primary dilution, the prescribed time, and the temperature during mixing.

Claims (24)

1. A method of manufacturing a lipid particle with a desired particle size, the method comprising:

(A) preparing a primary diluting solution by mixing a first solution comprising a lipid and alcohol with a second solution comprising water in a first mixing region;

(B) supplying the primary diluting solution from the first mixing region to a second mixing region through a liquid supplying tube in a predetermined time; and

(C) preparing a secondary diluting solution by mixing the primary diluting solution with a third solution comprising water in the second mixing region;

wherein steps (A) to (C) are performed sequentially, and

wherein a particle size of a lipid particle is controlled by adjusting at least one condition including the predetermined time

wherein the lipid particle is further loaded with a drug, and wherein the method further comprises, before step (A):

(A-1) measuring a chronological change in a particle size of a lipid particle loaded with the drug under a condition where the concentration of the alcohol is constant;

wherein at least one condition required for adjusting the desired particle size including the predetermined time is determined based on information obtained by step (A-1).

2. The method of claim 1 , wherein the particle size of the lipid particle is controlled by further adjusting at least one condition selected from the group consisting of a concentration of the alcohol, a concentration of the lipid, and a temperature upon the mixing.

3. The method of claim 1 , the predetermined time is adjusted in the range of 0.1 to 60 minutes.

4. The method of claim 1 , which manufactures lipid particles with a particle size distribution with a PDI of less than 0.1.

5. The method of claim 1 , wherein the adjusting the predetermined time comprises selecting a tube having a predetermined length as the liquid supplying tube.

6. The method of claim 5 , wherein the length of the liquid supplying tube is adjusted between 10 m to 40 m.

7. The method of claim 1 , wherein the adjusting the predetermined time comprises adjusting flow rate in the liquid supplying tube.

8. The method of claim 1 , wherein the lipid particle is a liposome or a micelle.

9. The method of claim 1 , wherein the method further comprises, before step (A):

(A-2) measuring a particle size of a lipid particle formed when a concentration of the alcohol is changed by diluting a solution comprising the drug, the lipid, and the alcohol;

wherein the at least one condition required for adjusting the desired particle size selected from the group consisting of the concentration of the alcohol in the primary diluting solution, the concentration of the lipid, the predetermined time, and the temperature upon the mixing is determined based on information obtained by step (A-2) together with the information obtained by step (A-1).

10. The method of claim 1 , wherein the alcohol concentration in the primary diluting solution is adjusted to 18 wt % or greater.

11. The method of claim 1 , wherein steps (A) to (C) are performed in a closed system.

12. The method of claim 1 , wherein additional particle size controlling processing is not performed after step I.

13. The method of claim 1 , wherein a pressure in the liquid supplying tube is 1 Mpa or greater.

14. The method of claim 1 , wherein the secondary diluting solution is further supplied to a hollow fiber membrane column.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2020
From: MATSUZAKI, TAKASHI
To: OSAKA UNIVERSITY
Reel/Frame 052937/0676 →
Priority Claims (1)
JP JP2017-212020 · Nov 1, 2017 · national
Continuity (1)
Related Publication 20210259971A1 · Aug 26, 2021